BCL2 and cancer: When we cocultured these APG-2575-treated cancer cells with genetic alteration of BCL-2 with IL-4-activated macrophages, we found that neither downregulation nor upregulation of BCL-2 in the cancer cells altered the expression of M1/M2-related markers (Supplementary Fig. S5F, G).